MHRA Symposium reveals massive and dangerous changes to UK medicines regulation

MHRA not fit for purpose!

For those who prefer not to subscribe, but want access to reasonably priced, easy to read books on the subject matter, feel free to check out on the button below:

The Symposium

Some of you may remember that I attended this MHRA Symposium last February on behalf of UK Column:

Good Manufacturing and Distribution Practice Symposia 2023, 21 February - 22 February 2023, Novotel London West / Virtual

I’d given you a heads up in this previous post:

Next few weeks, I'll be revealing important facts on MHRA, mRNA, and point of care manufacturing

There was a little taster in there, a la:

“just imagine if Microsoft became the sole provider of technology services to MHRA? What if that involved harvesting patient data, licensing pharmaceutical wholesalers, approving new drugs—not approving others, competitors maybe? What if surveillance activities to catch criminals (supposedly) thieving medicines was used by MHRAs criminal investigations team, using the latest MS AI App?”

Well, this is what was revealed on the day:

1. MHRA is now a Sovereign Agency - it can make it’s own rules up.